BlackRock Fund Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1K | Buy |
27
+5
| +23% | +$185 | ﹤0.01% | 4223 |
|
|
2016
Q3 | $0 | Buy |
22
+2
| +10% | – | ﹤0.01% | 4280 |
|
|
2016
Q2 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 4310 |
|
|
2015
Q2 | – | Sell |
-318
| Closed | -$43K | – | 3915 |
|
|
2015
Q1 | $43K | Sell |
318
-22
| -6% | -$2.98K | ﹤0.01% | 3709 |
|
|
2014
Q4 | $61K | Buy |
340
+24
| +8% | +$4.31K | ﹤0.01% | 3660 |
|
|
2014
Q3 | $76K | Sell |
316
-23
| -7% | -$5.53K | ﹤0.01% | 3672 |
|
|
2014
Q2 | $148K | Buy |
339
+10
| +3% | +$4.37K | ﹤0.01% | 3568 |
|
|
2014
Q1 | $151K | Buy |
329
+40
| +14% | +$18.4K | ﹤0.01% | 3526 |
|
|
2013
Q4 | $139K | Buy |
289
+12
| +4% | +$5.77K | ﹤0.01% | 3523 |
|
|
2013
Q3 | $133K | Buy |
277
+22
| +9% | +$10.6K | ﹤0.01% | 3503 |
|
|
2013
Q2 | $120K | Buy |
+255
| New | +$120K | ﹤0.01% | 3484 |
|